Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Longeveron Inc. (LGVN) Cash Flow Statement

Longeveron Inc. (LGVN) generated -$20.4M of operating cash flow over the twelve months to 2026-06-30, spent $160000 on capital expenditure and had free cash flow of -$20.5M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

LGVNLongeveron Inc.Follow LGVN — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
5.1M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days
LineFY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow—-9.6-14.0-19.0-13.9-18.6-20.4
Capital expenditure—0.30.60.30.70.2-0.2
Free cash flow—-10.0-14.5-19.3-14.5-18.9-20.5
Stock-based compensation—1.32.22.02.31.7—

USD millions · SEC XBRL

Longeveron Inc. — questions

What is Longeveron Inc.'s operating cash flow?
-$20.4M over the twelve months to 2026-06-30.
How much does Longeveron Inc. spend on capital expenditure?
$160000 over the twelve months to 2026-06-30.
What is Longeveron Inc.'s free cash flow?
-$20.5M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Longeveron Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.